Inhibition of c-Myc or cyclin D1 activity eliminates oestrogen-stimulated proliferation of breast cancer cells, while induction of c-Myc or cyclin D1 can mimic the effects of oestrogens. The gene discussed is CCND1; the disease is breast carcinoma.